326 related articles for article (PubMed ID: 33436510)
21. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
[TBL] [Abstract][Full Text] [Related]
22. The Gut-Renal Connection in IgA Nephropathy.
Coppo R
Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches.
Wu H; Tang D; Zheng F; Li S; Zhang X; Yin L; Liu F; Dai Y
Ann Transl Med; 2021 Jan; 9(1):32. PubMed ID: 33553325
[TBL] [Abstract][Full Text] [Related]
24. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling.
Tan J; Dong L; Jiang Z; Tan L; Luo X; Pei G; Qin A; Zhong Z; Liu X; Tang Y; Qin W
J Transl Med; 2022 Aug; 20(1):382. PubMed ID: 36038927
[TBL] [Abstract][Full Text] [Related]
25. The Genetics of IgA Nephropathy: An Overview from China.
Zhu L; Zhang H
Kidney Dis (Basel); 2015 May; 1(1):27-32. PubMed ID: 27536662
[TBL] [Abstract][Full Text] [Related]
26. Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy.
Cai F; Zhou C; Jiao N; Liang X; Ye Z; Chen W; Yang Q; Peng H; Tang Y; Niu C; Zhao G; Wang Z; Zhang G; Yu X
Microbiol Spectr; 2023 Jun; 11(3):e0520222. PubMed ID: 37227280
[TBL] [Abstract][Full Text] [Related]
27. Variants in genes of innate immunity, appetite control and energy metabolism are associated with host cardiometabolic health and gut microbiota composition.
Ortega-Vega EL; Guzmán-Castañeda SJ; Campo O; Velásquez-Mejía EP; de la Cuesta-Zuluaga J; Bedoya G; Escobar JS
Gut Microbes; 2020 May; 11(3):556-568. PubMed ID: 31154934
[TBL] [Abstract][Full Text] [Related]
28. Expansion of
Zhao J; Bai M; Ning X; Qin Y; Wang Y; Yu Z; Dong R; Zhang Y; Sun S
J Am Soc Nephrol; 2022 Dec; 33(12):2276-2292. PubMed ID: 36041791
[TBL] [Abstract][Full Text] [Related]
29. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide associations of human gut microbiome variation and implications for causal inference analyses.
Hughes DA; Bacigalupe R; Wang J; Rühlemann MC; Tito RY; Falony G; Joossens M; Vieira-Silva S; Henckaerts L; Rymenans L; Verspecht C; Ring S; Franke A; Wade KH; Timpson NJ; Raes J
Nat Microbiol; 2020 Sep; 5(9):1079-1087. PubMed ID: 32572223
[TBL] [Abstract][Full Text] [Related]
31. Joint contributions of the gut microbiota and host genetics to feed efficiency in chickens.
Wen C; Yan W; Mai C; Duan Z; Zheng J; Sun C; Yang N
Microbiome; 2021 Jun; 9(1):126. PubMed ID: 34074340
[TBL] [Abstract][Full Text] [Related]
32. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
[TBL] [Abstract][Full Text] [Related]
33. Genetics of IgA nephrology: risks, mechanisms, and therapeutic targets.
Qu S; Zhou XJ; Zhang H
Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38600219
[TBL] [Abstract][Full Text] [Related]
34. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
[TBL] [Abstract][Full Text] [Related]
35. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
[TBL] [Abstract][Full Text] [Related]
37. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
38. Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls.
Sanders JT; Hastings MC; Moldoveanu Z; Novak J; Julian BA; Bursac Z; Wyatt RJ
Int J Nephrol; 2017; 2017():8210641. PubMed ID: 29333295
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
40. Genetic study of immunoglobulin A nephropathy: From research to clinical application.
Li M; Yu X
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():26-31. PubMed ID: 30298665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
